News

Global Syndromic Multiplex Diagnostic Market Research: Key Companies Profile with Sales, Revenue, Price and Competitive Situation Analysis

Global Syndromic Multiplex Diagnostic Market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains the data of the base year 2018 and historic year 2017. Increasing demand for accurate results is major factor for the growth of this market.

Global Syndromic Multiplex Diagnostic Market By Infectious Diseases (HIV, HBV, HCV, HPV, Influenza, CTGC, Tuberculosis, MRSA, VRE), Syndrome (Bloodstream, Respiratory, Gastrointestinal, Central Nervous System), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Request for Free Report Sample@ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-syndromic-multiplex-diagnostic-market

Market Analysis: Global Syndromic Multiplex Diagnostic Market

Global Syndromic Multiplex Diagnostic Market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains the data of the base year 2018 and historic year 2017.  Increasing demand for accurate results is major factor for the growth of this market.

Market Definition: Global Syndromic Multiplex Diagnostic Market

Syndromic multiplex diagnostic is the test which is used to identify respiratory infection, infective gastroenteritis, and other viral, bacterial or fungal infections. They help the clinicians to identify the symptoms and signs of the disease. It helps the healthcare provider to provide correct patient care. It provides result more accurately so that treatment can be done immediately and faster.

Market Drivers

  • Increasing demand for accurate and fast results is driving the growth of this market
  • Affordable price of this test is another factor driving the market

Market Restraints

  • Lack of acceptance by doctors is restraining the market growth
  • The inability to detect asymptomatic cases is another major factor restraining the market

Segmentation: Global Syndromic Multiplex Diagnostic Market

By Infectious Diseases

  •  HIV – Human Immunodeficiency Virus (AIDS)
    • Virology
      • Classification
      • Structure and Genome
      • Tropism
      • Replication Cycle
      • Genetic Variability
    • Diagnosis
    • Testing
      • Antibody Tests
      • Point of Care Tests (POCT)
      • Antigen Tests
      • Nucleic Acid-based Tests (NAT)
      • Other Tests Used in HIV Treatment
  •  HBV – Hepatitis B
    • Virology
      • Genome
      • Pathogenesis
      • Hepatitis B Virus Replication
      • Serotypes and Genotypes
      • Diagnosis
        • Cervical Testing
        • Oral Testing
        • Testing Men
        • Other Testing
      •  Influenza
        • Virology
          • Influenza A virus
          • Influenza B virus
          • Influenza C virus
          • Structure, Properties, and Subtype Nomenclature
          • Replication
        • Testing

By Syndrome

  •  Bloodstream
  •  Respiratory
  •  Gastrointestinal
  •  Central Nervous System

Key Developments in the Market:

  • In November 2018, bioMérieux announced that they have got approval from Food and Drug Administration (FDA) for their BIOFIRE FILMARRAY Pneumonia Panel and the CE-Mark of the BIOFIRE FILMARRAY Pneumonia Panel plus which is specially designed for the diagnosis of respiratory infections. It will help the clinicians to identify the microorganisms that cause similar problems that too quickly and reliably.
  • In October 2018, QIAGEN N.V. announced the launch of their next-generation QIAstat-Dx panel which is used for identify gastrointestinal (GI) syndromes. This is designed in such a way so that hospitals, laboratories and clinics can be easy to use and diagnose the complex syndromes easily. The main aim is to meet the growing demand for syndromic testing.

Competitive Analysis: Global Syndromic Multiplex Diagnostic Market

Global syndromic multiplex diagnostic market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of syndromic multiplex diagnostic market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Request for Free TOC@ https://www.databridgemarketresearch.com/toc?dbmr=global-syndromic-multiplex-diagnostic-market

Key Market Competitors: Global Syndromic Multiplex Diagnostic Market

Few of the major competitors currently working in the syndromic multiplex diagnostic market are Abbott, Accelerate Diagnostics, Inc., Akonni Biosystems, Inc., Alveo Technologies, Applied BioCode, Inc., Binx Health, Inc., BD, Biocartis,  BioFire Diagnostics, bioMérieux SA, Bio-Rad Laboratories, Inc, Bosch Healthcare Solutions GmbH, Cepheid,  Diagenode Diagnostics, GenePOC Inc,  GenMark Diagnostics, Inc., Hologic, Inc.,   Inflammatix, Inc., Janssen Global Services, LLC, Mesa Biotech.